Stocksigma LogoStocksigma Logo

Sandu Pharmaceuticals Approves Key Board Appointments at 41st AGM

Sandu Pharmaceuticals Limited announced that shareholders approved key board appointments at the 41st AGM on 11th Sep'26

Sandu Pharmaceuticals Approves Key Board Appointments at 41st AGM

Sandu Pharmaceuticals Ltd 路 Change in Management 路 12 Sept 2026, 9:46 pm

Sandu Pharmaceuticals Approves Key Board Appointments at 41st AGM Sandu Pharmaceuticals Limited announced that shareholders approved key board appointments at the 41st AGM on 11th Sep'26. Shri Balram Viswanathan has been redesignated as Chairman and Managing Director for a 3-year term effective 11th Jul'26. Additionally, Dr. Neeti Madan Kapre has been appointed as a Non-Executive Independent Director for a 5-year term, effective 11th Jul'26, not liable to retire by rotation. Neither appointee is related to any director, key managerial personnel, or promoter, nor debarred by SEBI.

Original exchange filing (PDF)

More announcements from Sandu Pharmaceuticals Ltd

All Sandu Pharmaceuticals Ltd announcements